Selective BH3 mimetics synergize with BET inhibition to induce mitochondrial apoptosis in rhabdomyosarcoma cells
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Selective BH3 mimetics synergize with BET inhibition to induce mitochondrial apoptosis in rhabdomyosarcoma cells
Authors
Keywords
Apoptosis, BH3 mimetics, BET proteins, Rhabdomyosarcoma
Journal
NEOPLASIA
Volume 24, Issue 2, Pages 109-119
Publisher
Elsevier BV
Online
2021-12-24
DOI
10.1016/j.neo.2021.11.012
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting BCL-2 proteins in pediatric cancer: Dual inhibition of BCL-XL and MCL-1 leads to rapid induction of intrinsic apoptosis
- (2020) Sarah Kehr et al. CANCER LETTERS
- Co-inhibition of BET proteins and PI3Kα triggers mitochondrial apoptosis in rhabdomyosarcoma cells
- (2020) Cathinka Boedicker et al. ONCOGENE
- Super-Enhancer Redistribution as a Mechanism of Broad Gene Dysregulation in Repeatedly Drug-Treated Cancer Cells
- (2020) Qi Ma et al. Cell Reports
- Superior efficacy of cotreatment with BET protein inhibitor and BCL2 or MCL1 inhibitor against AML blast progenitor cells
- (2019) Warren Fiskus et al. Blood Cancer Journal
- Co-targeting of BET proteins and HDACs as a novel approach to trigger apoptosis in rhabdomyosarcoma cells
- (2018) Julius C. Enßle et al. CANCER LETTERS
- The MCL1-specific inhibitor S63845 acts synergistically with venetoclax/ABT-199 to induce apoptosis in T-cell acute lymphoblastic leukemia cells
- (2018) Zhaodong Li et al. LEUKEMIA
- BCL-2 selective inhibitor ABT-199 primes rhabdomyosarcoma cells to histone deacetylase inhibitor-induced apoptosis
- (2018) Ulrike Heinicke et al. ONCOGENE
- The novel BET bromodomain inhibitor BI 894999 represses super-enhancer-associated transcription and synergizes with CDK9 inhibition in AML
- (2018) Daniel Gerlach et al. ONCOGENE
- Arsenic sulfide amplifies JQ1 toxicity via mitochondrial pathway in gastric and colon cancer cells
- (2018) Zhen Tan et al. Drug Design Development and Therapy
- Targeting BET proteins improves the therapeutic efficacy of BCL-2 inhibition in T-cell acute lymphoblastic leukemia
- (2017) S Peirs et al. LEUKEMIA
- BH3-mimetics and BET-inhibitors elicit enhanced lethality in malignant glioma
- (2017) Chiaki Tsuge Ishida et al. Oncotarget
- Generation and characterization of ErbB2-CAR-engineered cytokine-induced killer cells for the treatment of high-risk soft tissue sarcoma in children
- (2017) Michael Merker et al. Oncotarget
- The BCL2 selective inhibitor venetoclax induces rapid onset apoptosis of CLL cells in patients via a TP53-independent mechanism
- (2016) M. A. Anderson et al. BLOOD
- Physiological restraint of Bak by Bcl-xLis essential for cell survival
- (2016) Erinna F. Lee et al. GENES & DEVELOPMENT
- The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models
- (2016) András Kotschy et al. NATURE
- Kinase and BET Inhibitors Together Clamp Inhibition of PI3K Signaling and Overcome Resistance to Therapy
- (2015) Elias E. Stratikopoulos et al. CANCER CELL
- Chemosensitization of rhabdomyosarcoma cells by the histone deacetylase inhibitor SAHA
- (2014) Ulrike Heinicke et al. CANCER LETTERS
- The Carboxyl-terminal Tail of Noxa Protein Regulates the Stability of Noxa and Mcl-1
- (2014) Xiaming Pang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
- (2013) Andrew J Souers et al. NATURE MEDICINE
- Decreased mitochondrial apoptotic priming underlies stroma-mediated treatment resistance in chronic lymphocytic leukemia
- (2012) M. S. Davids et al. BLOOD
- Fiji: an open-source platform for biological-image analysis
- (2012) Johannes Schindelin et al. NATURE METHODS
- Bcl-xL-inhibitory BH3 mimetics can induce a transient thrombocytopathy that undermines the hemostatic function of platelets
- (2011) S. M. Schoenwaelder et al. BLOOD
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
- (2011) Jake E. Delmore et al. CELL
- Acquired resistance to ABT-737 in lymphoma cells that up-regulate MCL-1 and BFL-1
- (2010) D. Yecies et al. BLOOD
- The landscape of somatic copy-number alteration across human cancers
- (2010) Rameen Beroukhim et al. NATURE
- Selective inhibition of BET bromodomains
- (2010) Panagis Filippakopoulos et al. NATURE
- Molecular and cellular biology of rhabdomyosarcoma
- (2009) Carla De Giovanni et al. Future Oncology
- Differential Regulation of Bax and Bak by Anti-apoptotic Bcl-2 Family Proteins Bcl-B and Mcl-1
- (2008) Dayong Zhai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Bcl-XL Inhibits Membrane Permeabilization by Competing with Bax
- (2008) Lieven P Billen et al. PLOS BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search